Target intelligence / Profile preview

RNA, U7 Small Nuclear 169 Pseudogene (RNU7-169P)

Target
RNU7-169P
Molecular classification
Pseudogene (noncoding RNA pseudogene)
01

Overview

RNU7-169P (RNA, U7 Small Nuclear 169 Pseudogene) is a human pseudogene located on chromosome 12 and listed under the HGNC symbol 45703[3][7]. Pseudogenes are genomic sequences similar to known genes but carry disabling mutations that prevent protein or functional RNA production[4][2]. Unlike its functional counterpart RNU7-1—which is a critical component of the U7 small nuclear ribonucleoprotein (snRNP) complex involved in histone pre-mRNA processing—RNU7-169P does not encode an active RNA molecule and is not involved in known biological processes[1][7]. There are currently no drugs, disease associations, or regulatory data implicating RNU7-169P in human pathophysiology or as a marker for therapeutic intervention[7]. While some pseudogenes are increasingly recognized for their potential regulatory RNA roles, either affecting parental gene expression or acting as decoys for microRNAs[2], there is no specific annotation or research supporting such a function for RNU7-169P. Its classification as a pseudogene is supported by major genetic databases and biotype guidelines, indicating it contains mutations or disruptions that render it nonfunctional[4][7]. RNU7-169P is a canonical pseudogene—accurately named and nonfunctional—with no current evidence of biological or therapeutic targeting potential, drug interaction, or biomarker status[7]. Any structured data extraction should reflect its status as a genomic pseudogene, not a therapeutic or functional target.

Other names
RNU7-169PRNA, U7 Small Nuclear 169 PseudogeneGC12P108668
02

Biological functions

No established direct biological function
03

Disease associations

No established disease association or causative role

Beyond the preview

Go deeper on RNA, U7 Small Nuclear 169 Pseudogene (RNU7-169P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 Small Nuclear 169 Pseudogene (RNU7-169P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call